119-hr2075

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2075 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 2075

 To prohibit the Federal Government from conducting or supporting any 
 research involving human fetal tissue that is obtained pursuant to an 
 induced abortion, and to prohibit the solicitation or knowing 
 acquisition, receipt, or acceptance of a donation of such tissue.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 March 11, 2025

 Mr. Onder (for himself, Mr. Smith of New Jersey, Mr. Latta, Mr. Kelly 
 of Mississippi, Mrs. Miller of Illinois, Mr. Harris of Maryland, Mr. 
Green of Tennessee, Mr. LaMalfa, Mr. Grothman, Mr. Cloud, Mr. Self, Mr. 
 Weber of Texas, Mr. Stauber, Mr. Ellzey, Mr. Ezell, Mr. Guest, Mr. 
 Burchett, Mr. Crane, Mr. Fallon, Mrs. Biggs of South Carolina, Mr. 
 Palmer, Mr. Biggs of Arizona, Ms. Greene of Georgia, and Mr. 
 Fleischmann) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce

_______________________________________________________________________

 A BILL

 To prohibit the Federal Government from conducting or supporting any 
 research involving human fetal tissue that is obtained pursuant to an 
 induced abortion, and to prohibit the solicitation or knowing 
 acquisition, receipt, or acceptance of a donation of such tissue.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Protecting Life and Integrity in 
Research Act of 2025''.

SEC. 2. NO RESEARCH INVOLVING HUMAN FETAL TISSUE OBTAINED PURSUANT TO 
 AN INDUCED ABORTION.

    (a) In General.--

    (1) In general.--No Federal department, agency, or office 
 may conduct, fund, approve, or otherwise support any research 
 involving human fetal tissue that is obtained pursuant to an 
 induced abortion.

    (2) Development of new, ethical cell lines.--Subsection

    (a) does not limit the authority of any Federal department, agency, 
 or office to develop or support the development of new, high-
 efficiency cell lines, including for the production of vaccines 
 and genetic vectors, so long as the cell lines are not derived 
 from human fetal tissue that is obtained pursuant to an induced 
 abortion.

    (3) Research involving human fetal tissue obtained after a 
 miscarriage or stillbirth permitted.--Any research of any 
 Federal department, agency, or office on human fetal tissue 
 obtained after a miscarriage or stillbirth shall be conducted 
 or supported in accordance with 

section 498A of the Public 
 Health Service Act (42 U.S.C. 289g-1).

    (b) Amendments to the PHSA Limiting Human Fetal Tissue Research to 
Tissue Obtained After a Miscarriage or Stillbirth.--

Section 498A of the 
Public Health Service Act (42 U.S.C. 289g-1) is amended--

    (1) in the section heading, by striking ``transplantation 
 of fetal tissue'' and inserting ``human fetal tissue obtained 
 after a miscarriage or stillbirth'';

    (2) by amending subsection

    (a) to read as follows:
 ``

    (a) Establishment of Program.--The Secretary may conduct or 
support research on human fetal tissue obtained after a miscarriage or 
a stillbirth.'';

    (3) in subsection

    (b) --
        (A) in paragraph

    (1)
        (B) , by inserting ``if the 
 human fetal tissue is intended for transplantation,'' 
 before ``the donation''; and
        (B) in paragraph

    (2) --
            (i) by striking subparagraph
        (A) ; and
            (ii) by redesignating subparagraphs
        (B) and
            (C) as
        (A) and
        (B) , respectively;

    (4) in subsection
            (c) (1)
        (B) , by striking ``pursuant to a 
 spontaneous or induced abortion or pursuant to'' and inserting 
 ``after a miscarriage or''; and

    (5) by amending subsection

    (g) to read as follows:
 ``

    (g) 

=== Definitions. ===
-In this section:
 ``

    (1) Human fetal tissue.--The term `human fetal tissue' 
 means tissue or cells obtained from a dead unborn child 
 pursuant to an induced abortion, a miscarriage, or a 
 stillbirth.
 ``

    (2) Miscarriage.--The term `miscarriage' means the 
 involuntary death of an unborn child who was carried in the 
 womb for a period of less than 20 weeks.
 ``

    (3) Stillbirth.--The term `stillbirth' means the 
 involuntary death of an unborn child who was carried in the 
 womb for a period of 20 weeks or more.
 ``

    (4) Unborn child.--The term `unborn child' has the 
 meaning given such term in 

section 1841
            (d) of title 18, United 
 States Code.''.
            (c) Conforming Repeal.--

Section 113 of the National Institutes of 
Health Revitalization Act of 1993 (42 U.S.C. 289g-1 note) is repealed.

SEC. 3. PROHIBITION AGAINST SOLICITATION OR KNOWING ACQUISITION, 
 RECEIPT, OR ACCEPTANCE OF A DONATION OF HUMAN FETAL 
 TISSUE KNOWING THAT THE TISSUE WAS OBTAINED PURSUANT TO 
 AN INDUCED ABORTION.

    (a) In General.--

Section 498B
            (c) (1) of the Public Health Service 
Act (42 U.S.C. 289g-2
            (c) (1) ) is amended to read as follows:
 ``

    (1) solicit or knowingly acquire, receive, or accept a 
 donation (excluding any transfer for purposes of autopsy or 
 burial) of human fetal tissue knowing that--
 ``
        (A) a human pregnancy was deliberately initiated 
 to provide such tissue; or
 ``
        (B) the tissue was obtained pursuant to an 
 induced abortion; or''.

    (b) Conforming Changes.--

Section 498B of the Public Health Service 
Act (42 U.S.C. 289g-2), as amended by subsection

    (a) , is further 
amended--

    (1) by striking subsection

    (b) ;

    (2) by redesignating subsections
            (c) through

    (e) as 
 subsections

    (b) through
            (d) , respectively; and

    (3) in subsection
            (c) , as redesignated--
        (A) in paragraph

    (1) , by striking ``

    (a) ,

    (b) , or
            (c) '' and inserting ``

    (a) or

    (b) ''; and
        (B) in paragraph

    (2) , by striking ``or

    (b)

    (3) ''.
 <all>